Evidence map›Paper›PMID 34158824›Full record

ArticleEcancermedicalscience2021

Survivor and parent engagement in childhood cancer treatment in Iran.

Shirin Ahmadnia, Atena Kamel Ghalibaf, Saba Kamkar, Zahra Mohamadzadeh, Mithra Ghalibafian

Open access · goldAbstract read
In one paragraph

Article in Ecancermedicalscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Exploring treatment decision-making at diagnosis for children with advanced cancer in low- and middle-income countries.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shirin AhmadniaAllameh Tabataba`i University, Tehran 1489684511, Iran.
Atena Kamel GhalibafAllameh Tabataba`i University, Tehran 1489684511, Iran.
Saba KamkarMAHAK Charity-Society to Support Children Suffering from Cancer, Tehran 1956993461, Iran.
Zahra MohamadzadehMAHAK Charity-Society to Support Children Suffering from Cancer, Tehran 1956993461, Iran.
Mithra GhalibafianMAHAK Paediatric Cancer Treatment and Research Centre (MPCTRC), Tehran 1956993461, Iran.
Mahak Hospital and Rehabilitation Complex · IRAllameh Tabataba'i University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Iran (with a population of 83 million), 19,973 children were diagnosed with cancer from 2009 to 2019 (MAHAK Charity). This study was part of the International Society of Paediatric Oncology, Paediatric Oncology in Developing Countries Committee, 'Patient, Family and Stakeholder Engagement Task Force' engagement study in ten low- and middle-income countries in 2019. We documented childhood cancer survivors and parents' experiences and quality of engagement, including perceptions and expectations, during their cancer treatment journey in Iran. Fourteen in-depth interviews and three focus group discussions were conducted by three Iranian qualitative researchers with 29 participants: recent adolescent/young adult survivors (12-20 years), long-term survivors (21-30 years) and parents [36-61 years (six mothers and four fathers)] from diverse socio-economic and ethnic backgrounds. Data were recorded, transcribed and analysed, and then translated from Farsi into English. Participants' expectations included

Indexed as

adolescentcancer survivorscommunicationengagementIranparentsphysician–patient relationships

Identifiers

PMID34158824
PMCPMC8183647
OpenAlexW3156091804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.